Your browser doesn't support javascript.
loading
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis.
Zhao, Shuang G; Chang, S Laura; Spratt, Daniel E; Erho, Nicholas; Yu, Menggang; Ashab, Hussam Al-Deen; Alshalalfa, Mohammed; Speers, Corey; Tomlins, Scott A; Davicioni, Elai; Dicker, Adam P; Carroll, Peter R; Cooperberg, Matthew R; Freedland, Stephen J; Karnes, R Jeffrey; Ross, Ashley E; Schaeffer, Edward M; Den, Robert B; Nguyen, Paul L; Feng, Felix Y.
Afiliação
  • Zhao SG; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Chang SL; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Erho N; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Yu M; Department of Biostatistics & Medical Informatics, University of Wisconsin, Madison, WI, USA.
  • Ashab HA; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Alshalalfa M; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Speers C; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
  • Tomlins SA; Department of Pathology, Department of Urology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA.
  • Davicioni E; GenomeDx Biosciences, Vancouver, BC, Canada.
  • Dicker AP; Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
  • Carroll PR; Department of Urology, University of California at San Francisco, San Francisco, CA, USA; Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA.
  • Cooperberg MR; Department of Urology, University of California at San Francisco, San Francisco, CA, USA; Helen Diller Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA.
  • Freedland SJ; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Ross AE; James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
  • Schaeffer EM; Department of Urology, Northwestern University, IL, USA.
  • Den RB; Department of Radiation Oncology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA, USA.
  • Nguyen PL; Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA.
  • Feng FY; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA; Michigan Center for Translational Pathology, Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, USA; Dep
Lancet Oncol ; 17(11): 1612-1620, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27743920
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos